Lonsurf
Product Description of Lonsurf (Trifluridine and Tipiracil)
Lonsurf is a prescription medication that combines two active ingredients: Trifluridine and Tipiracil. It is primarily used for the treatment of metastatic colorectal cancer in patients who have previously undergone chemotherapy.
How Lonsurf Works
The active component Trifluridine is an antineoplastic agent that interferes with DNA synthesis, preventing cancer cells from multiplying. Tipiracil, on the other hand, enhances the effectiveness of Trifluridine by inhibiting its breakdown, thereby increasing its concentration in the body.
Indications
Lonsurf is indicated for patients with:
- Metastatic colorectal cancer who have received prior treatments.
- Patients with no access to curative treatment options.
Dosage and Administration
Patients should take Lonsurf twice daily, with a specific schedule typically involving a cycle of treatment followed by a rest period. It is important to follow the healthcare provider’s instructions regarding dosage and timing.
Potential Side Effects
Common side effects of Lonsurf may include:
- Nausea and vomiting
- Diarrhea
- Fatigue
- Decreased appetite
Patients should report any severe or persistent side effects to their healthcare provider.
Precautions
Before starting Lonsurf, patients should inform their doctor of any pre-existing conditions, particularly bone marrow suppression, liver issues, or if they are pregnant or breastfeeding.
Drug Interactions
It is essential to discuss all medications and supplements being taken with a healthcare provider, as Lonsurf may interact with certain drugs, affecting their efficacy or increasing side effects.
Conclusion
Lonsurf offers a treatment option for patients with advanced colorectal cancer, helping to manage their condition when other therapies are no longer effective. Always consult with a healthcare professional for personalized medical advice.
